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Research
Responding to veterans’ concerns and as part 
of an ongoing medical surveillance program 
for U.S. military veterans exposed to depleted 
uranium (DU), biological monitoring of urine 
uranium (U) concentrations has been carried 
out by the Department of Veterans Affairs 
(VA) since the early 1990s. Since the first 
Gulf War in 1991, DU has been used both in 
armor-piercing projectiles and as armor itself, 
because of its high density, availability, and 
relative low cost [Army Environmental Policy 
Institute (AEPI) 1995].
A by-product of the U enrichment process, 
DU is the material remaining after the more 
radioactive U234 and U235 isotopes are removed 
from natural uranium (Unat) (AEPI 1995). DU 
thus possesses only about 60% of the radioac-
tivity of Unat but retains the elemental, chemi-
cal characteristics of this heavy metal.
Although DU was first deployed in the 
Gulf War in 1991 and was also used in the 
Bosnian conflicts, it has played less of a role 
in the present military campaigns in Iraq and 
Afghanistan. Despite this, health concerns 
persist about potential exposure risks, so sur-
veillance efforts have been expanded to offer 
biomonitoring to any veteran requesting a 
test for DU exposure.
Veterans access the biomonitoring pro-
gram through any VA clinic or hospital. 
The U.S. Navy and Air Force also use the 
VA’s DU biomonitoring program for their 
active-duty service members. The assessment 
includes a self-completed questionnaire and 
submission of a 24-hr urine sample, which 
is analyzed for total U concentration and for 
the presence of DU. With accompanying 
interpretation, results are returned to the vet-
eran and his or her health care provider. The 
questionnaire addresses specific DU exposure 
scenarios of concern to veterans. Examples 
of potential exposure opportunities include 
inhalation of smoke containing DU particles 
(e.g., during a fire involving DU weapons at 
Doha depot, Qatar), entering or salvaging 
vehicles or bunkers hit by DU projectiles, and 
reporting close contact with DU munitions 
in tanks and other vehicles.
Results of surveillance completed between 
August 1998 and December 1999 and 
between January 2000 and December 2002 
have been previously reported (McDiarmid 
et al. 2001a, 2004a). Both studies concluded 
that a veteran without a history of traumatic 
injury involving DU munitions would be 
unlikely to have an elevated urine U value.
In the 5 years since the last report of these 
surveillance results, 1,769 additional urine 
samples have been measured. In addition, we 
can now accurately perform determinations of 
U isotopic signatures at very low total U con-
centrations, enabling accurate identification 
of DU as opposed to Unat. This capability has 
significantly enhanced our ability to assess 
DU exposure. We report here an update of 
these results.
Materials and Methods
Program enrollment. From January 2003 
through June 2008, 1,769 veterans and active-
duty service members from the U.S. Navy 
and Air Force who served in the 1991 Gulf 
War and/or who have served since the end of 
the Gulf War (referred to as post-Gulf War 
veterans) provided 24-hr urine samples for 
U testing. The latter group includes veterans 
of the military conflicts in Iraq, Afghanistan, 
and the Balkans. The veterans’ local VA or the 
service members’ medical treatment facility 
contacted the DU program at the Baltimore 
VA Medical Center (BVAMC) to request 
a test kit and coordinated collection of the 
urine sample. As previously reported, the kit 
contained a demographic and exposure ques-
tionnaire, instructions for the collection and 
handling of the 24-hr urine specimen, and 
urine collection containers (McDiarmid et al. 
2001a, 2004a). The collected specimen was 
returned to the BVAMC for processing. This 
protocol has been reviewed and approved 
by the University of Maryland School of 
Medicine Institutional Review Board and 
the Research and Development Office at the 
BVAMC. Personnel at the local VA hospital, 
clinic, or medical treatment facility obtained 
consent for medical evaluation. Informed 
consent requirements for the purposes of 
population surveillance were waived after 
review by the University of Maryland School 
of Medicine Institutional Review Board.
Urine U analytic methods. Measurements 
of total volume and creatinine in the 24-hr 
urine samples were made at the BVAMC 
clinical labs. Before July 2003, U concen-
trations for Gulf War veterans were mea-
sured by STL Richland (formerly Quanterra, 
Inc., and International Technology Analytic 
Services; Richland, WA) using kinetic phos-
phorescence analysis (KPA). When urine U 
concentrations were > 0.05 µg U/g creati-
nine, patients were asked to submit a second 
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sample for confirmation of the U concentra-
tion. Additionally, the presence of DU versus 
Unat in the samples was determined by isoto-
pic analysis at the Armed Forces Institute of 
Pathology (AFIP) in Washington, DC, using 
inductively coupled plasma mass spectrometry 
(ICP-MS) as described by Ejnik et al. (2005). 
Since July 2003, all urine samples, including 
those from Gulf War veterans, have under-
gone U quantification and isotopic analysis 
at AFIP.
Urine U distribution. We dichotomized 
urine U values into high U (≥ 0.05 µg U/g 
creatinine) and low U (< 0.05 µg U/g creati-
nine) for statistical analysis. The 0.05 µg U/g 
creatinine cut-point has been used in prior 
publications related to this surveillance popu-
lation (McDiarmid et al. 2001a, 2004a). We 
chose the value of 0.05 µg U/g creatinine 
because it was the approximate upper limit of 
the urine U distribution for nonoccupation-
ally exposed, geographically divergent popula-
tions available when this project began in the 
mid-1990s (Dang et al. 1992; Medley et al. 
1994). Although levels for the general popula-
tion are now available through the National 
Health and Nutrition Examination Survey 
(NHANES) database [Centers for Disease 
Control and Prevention (CDC) 2005], the 
cut-point of 0.05 µg U/g creatinine has been 
retained to allow comparison with prior stud-
ies. Also, the cut-point is near the NHANES 
95th percentile level (0.043 µg/g creatinine) 
for the general U.S. population ≥ 20 years of 
age (CDC 2005).
DU exposure history assessment.  As 
described previously (McDiarmid et al. 2001a), 
a team of VA and Department of Defense 
occupational health experts, health physicists, 
and field experts crafted a DU exposure ques-
tionnaire for use by military personnel. In the 
past, relationships between urine U concen-
tration and exposure history were evaluated 
for the entire surveillance population. These 
analyses revealed that the presence of a retained 
DU fragment from a traumatic injury was the 
only predictor of an elevated urine U concen-
tration. For this study, we analyzed exposure 
from questionnaire responses for only the sub-
set of samples with a urine U concentration 
≥ 0.05 µg U/g creatinine or isotopic analysis 
consistent with DU (n = 30).
Results
Between January 2003 and June 2008, we 
received 1,769 urine specimens for U analy-
sis: 404 specimens from veterans of the Gulf 
War and 1,365 from post-Gulf War veterans. 
Figure 1 provides a summary of the urine 
U biomonitoring activity and the isotopic 
  findings.
Urine U measures. Table 1 summarizes the 
mean and median urine U measures. The mean 
urine U concentration for the entire population 
of 1,769 individuals was 0.009 µg U/g creati-
nine. Mean urine U concentrations for Gulf 
War and post-Gulf War veterans were 0.008 
and 0.009 µg U/g creatinine, respectively, and 
did not differ statistically (p = 0.869). The 
median urine U measures were 0.004 (total 
group), 0.005 (Gulf War), and 0.004 (post-Gulf 
War) µg U/g creatinine.
Isotopic analysis was performed on 1,700 
of the 1,769 (96%) specimens. The pres-
ence or absence of DU is determined by the 
235U:238U ratio. A ratio between 0.0020 and 
0.0030 defines a sample that is primarily DU. 
A ratio between 0.006 and 0.009 defines Unat. 
A ratio between these two ranges describes a 
sample that is a mixture of DU and Unat. Only 
3 of the 1,700 (0.01%) specimens had an iso-
topic signature consistent with DU (ratios = 
0.0029, 0.0029, and 0.0030). Mean urine U 
levels are higher in the individuals with DU 
compared with those with no DU detected 
in the urine (0.036 vs. 0.008 µg U/g creati-
nine). These individuals had been involved 
in friendly fire incidents and had retained 
DU fragments. As previous work has demon-
strated, veterans with retained DU fragments 
continue to have elevated urine U levels com-
pared with those without embedded fragments 
(McDiarmid et al. 2000, 2001b, 2004b, 2006, 
2007, 2009). The remaining 1,697 specimens 
contained Unat at levels that would be expected 
in the general U.S. population.
Figure 2 shows the distribution of urine 
U values ranked from low to high urine U (µg 
U/g creatinine) for both the Gulf War and 
post-Gulf War veterans. The urine U values 
ranged from < 0.001 to 0.105 µg U/g crea-
tinine for the Gulf War specimens and from 
< 0.001 to 1.686 µg U/g creatinine for post-
Gulf War specimens. The three specimens 
isotopically identified as having DU are indi-
cated in Figure 2. Stratifying results into low 
(< 0.05 µg U/g creatinine) and high (≥ 0.05 
µg U/g creatinine) urine U groups resulted 
in only 2.2% of Gulf War samples and 1.5% 
of specimens from post-Gulf War veterans 
being in the “high” range. Horizontal lines are 
shown for comparing the urine U concentra-
tions obtained from the mail-in biomonitor-
ing program with urine U concentrations that 
occur from environmental and occupational 
exposures.
Ninety-seven percent (97%) of Gulf War 
and 98% of post-Gulf War veterans had urine 
U values below the 95th percentile value of 
0.043 µg U/g creatinine for the general U.S. 
population ≥ 20 years of age (CDC 2005). In 
addition, as shown in Figure 2, most sample 
concentrations fell below the mean urine U 
values found in two populations exposed to 
high Unat concentrations in drinking water 
supplies: 0.65 µg U/g creatinine (Kurttio et al. 
2002) and 0.397 µg U/g creatinine (Orloff 
et al. 2004). Nearly all urine U measurements 
were at least an order of magnitude below 
occupational exposures reported for U fabri-
cation workers in 1980 (Thun et al. 1985).
Exposure scenarios predictive of DU pres-
ence in urine. Thirty urine samples had a 
U concentration ≥ 0.05 µg U/g creatinine 
Figure 1. Summary of urine U surveillance activities from January 2003 through June 2008. The number of 
samples analyzed is stratified into Gulf War and post-Gulf War veterans. The results of isotopic analyses, 
which define the presence of DU are presented. “Unknown” indicates samples obtained before July 2003, 
when routine isotopic analysis on samples was initiated. The three samples with an isotopic signature 
consistent with DU were from individuals identified to have been injured as a result of friendly fire.
Samples analyzed between
January 2003 and June 2008
n = 1,769
Gulf War I
n = 404
Post Gulf War
n = 1,365
DU
n = 0
No DU
n = 335
Unknown
n = 69
DU
n = 3
No DU
n = 1,362
Table 1. Mean and median urine U values (µg U/g creatinine) in U.S. veterans.
  No.  Mean ± SE  Median
McDiarmid et al. (2001a)  169  0.020 ± 0.003  0.010
McDiarmid et al. (2004)  446a  0.023 ± 0.006  0.010
Samples from Gulf War veterans since January 2003   404  0.008 ± 0.001  0.005
Samples from post-Gulf War veteransb since January 2003  1,365  0.009 ± 0.001  0.004
All samples since January 2003  1,769  0.009 ± 0.001  0.004
aIncludes 169 samples from McDiarmid et al. (2001a). bVeterans who have served since the first Gulf War, including those 
serving in Iraq, Afghanistan, and the Balkans.Depleted uranium exposure monitoring in U.S. veterans
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and/or were isotopically consistent with DU. 
Review of the questionnaires submitted by 
these veterans revealed that only the pres-
ence of a retained fragment and involvement 
in an incident known to involve DU muni-
tions or DU armored vehicles predicted the 
presence of DU in the urine. This observa-
tion is consistent with previous findings from 
mailed-in specimens sent before January 2003 
(McDiarmid et al. 2001a, 2004a).
Discussion
The overwhelming majority (97%) of the 
1,769 urine specimens submitted by Gulf 
War and post-Gulf War veterans had urine 
U levels in the range of those found in the 
general U.S. population, that is, ≤ 95th per-
centile of NHANES results collected between 
2001 and 2002 (CDC 2005). More impor-
tantly, only 3 of the 1,700 urine specimens 
that underwent isotopic analysis had a DU 
isotopic signature. These three came from 
individuals reporting embedded fragments 
from DU friendly fire–related injury.
Only a small percentage of samples (2.2% 
Gulf War and 1.5% post-Gulf War) had urine 
U concentrations above the DU surveillance 
program’s cut-point of 0.05 µg U/g creati-
nine. The vast majority of these samples were 
Unat. The source of exposure for these individ-
uals was most likely drinking water. The con-
centration of U in drinking water varies across 
the United States and the world, depending 
on the composition of the local bedrock. For 
example, unusually high concentrations of 
Unat in drinking water have been found in 
areas of Finland (Kurttio et al. 2002), Canada 
(Zamora et al. 1998), and the United States 
(Orloff et al. 2004). Another potential source 
of Unat exposure may be related to residence 
near a uranium mine or mill.
The findings of this study are generally 
consistent with those reported previously for 
surveillance of Gulf War personnel performed 
between August 1998 and December 1999 
(McDiarmid 2001a) and from January 2000 
through December 2002 (McDiarmid 2004a) 
(see Table 1). We found no statistical differ-
ence in the means of the urine U between 
the 169 samples received from 1998 through 
1999 and the 277 samples received between 
2000 and 2002 (the earlier reports of mail-in 
surveillance results cited above). However, 
when we compared mean urine U measures 
for these two cohorts (0.020 and 0.023 µg 
U/g creatinine) with the mean of the 1,769 
samples reported here (0.009 µg U/g creati-
nine), we observed a statistically significant 
difference (p = 0.001). This difference can 
be explained by the change in the methodol-
ogy used to measure the urine U concentra-
tion value. As noted above, starting in July 
2003 samples were analyzed by ICP-MS. This 
methodology is more sensitive at lower urine 
U concentrations than is the KPA method 
formerly used to measure urine U concen-
trations. For samples collected and analyzed 
before 2003, we used the detection limit value 
for the KPA method in the calculation of the 
creatinine-standardized urine U concentra-
tions for samples with U concentrations at or 
below the detection limit. This small overes-
timate of urine U concentrations is likely the 
basis for the higher group averages calculated 
for the earlier two cohorts.
As mentioned above, isotopic analysis of 
the samples examined for this study detected 
only three individuals who are excreting DU in 
their urine. Levels of urine U are higher in this 
group of three compared with the isotopically 
Unat group (0.037 vs. 0.009 µg U/g creatinine). 
When we consider the entire surveillance popu-
lation, dating back to 1998 (n = 2,246), only 
a total of four individuals have been identi-
fied as excreting DU in their urine. Exposure 
history confirms that these four individuals 
were injured as a result of friendly fire and have 
retained embedded fragments.
The results reported here are also consis-
tent with those of another Department of 
Veterans Affairs–sponsored DU surveillance 
program, which has been following for 15 
years a dynamic cohort of 77 Gulf War veter-
ans with known exposure to DU from docu-
mented friendly fire incidents during the 1991 
Gulf War. Among this group, only those 
with retained DU fragments from traumatic 
injury continue to excrete higher concentra-
tions of U in their urine (McDiarmid et al. 
2000, 2001b, 2004b, 2006, 2007, 2009). 
Urine U levels in those without retained 
DU fragments, but who sustained a histori-
cally documented inhalation exposure dur-
ing the friendly fire incidents, are similar to 
general population levels and are isotopically 
  consistent with Unat.
The persistent elevation of urine U 
observed in those with retained fragments is 
supported by animal studies in which DU 
pellets implanted into the animals (Hahn 
et al. 2002; Pellmar et al. 1999) oxidized 
in situ, thus serving as a metal depot for 
ongoing systemic exposure. As the metal ions 
are released to the circulation, they are fil-
tered by the kidney and excreted in urine, 
resulting in higher U concentrations.
The data reported here on this expanded 
surveillance cohort of both Gulf War and 
more recently deployed soldiers and veterans 
confirm previous findings that, in the absence 
of retained DU fragments, it is highly unlikely 
that an individual will have chronically ele-
vated urine U.
Historically, concern has been raised about 
the long lag time between exposure during 
deployment and subsequent biomonitoring 
Figure 2. Distribution of urine U results from mail-in specimens from January 2003 through June 2008 plot-
ted as two separate groups: Gulf War (GWI) versus post-Gulf War (PGW) veterans. Samples are ranked 
from low to high urine U concentration. The different symbols within each group denote whether DU was 
identified in each of the urine samples. Only three specimens were isotopically consistent with DU in the 
PGW group. Reference lines are provided on this graph for comparison purposes: Mean total urine U found 
in a subcohort of U fabrication workers in 1980 (Thun et al. 1985); Means from two populations with known 
high levels of environmental exposure to Unat (Kurttio et al. 2002; Orloff et al. 2004); Cut-point established by 
the Depleted Uranium Follow-up Program to identify high versus low urine U concentrations (McDiarmid 
et al. 2001a); 95th percentile for urine U from the NHANES 2000–2001 population study for adults ≥ 20 years 
of age (CDC 2005); mean from the current cohort of 1,769 reported in the present study.
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performed years later. A transient U elevation 
from a one-time inhalation exposure could 
be missed if sampling occurred too long after 
U exposure, whereas measurements taken at 
the time of a potential exposure incident may 
indicate that an exposure to DU has occurred. 
Estimates reported by the Royal Society of 
London (2002) suggest that a DU oxide inha-
lation dose sufficiently high to cause signifi-
cant health effects would still be detectable 
10 years after exposure, using analytical tech-
niques currently available.
The rate of elimination of an inhaled dose 
of DU depends on many parameters, includ-
ing the chemical and physical form of the 
DU oxide particles inhaled and the exposure 
dose. Data collected as part of a U.S. Army 
DU aerosol characterization and risk assess-
ment study, which characterized DU aerosols 
created by the perforation of an Abrams tank 
and a Bradley Fighting Vehicle with a large-
caliber DU penetrator, indicate that soldiers 
in friendly fire incidents inhaled DU that 
was a mixture of soluble and insoluble DU 
oxides (Parkhurst et al. 2005). Soluble oxides 
would have been rapidly absorbed through 
the lungs and cleared by the kidney. Insoluble 
oxides would have been phagocytized by lung 
macrophages and cleared from alveolar areas 
either through the mucocilliary system to 
the mouth or by transport to lung-associated 
lymph nodes.
We also address the concern regarding the 
lag time between exposure and biomonitor-
ing by including veterans from recent mili-
tary conflicts in our surveillance program. We 
achieved a shortened time interval between 
potential initial exposure and assessment of 
urine U with this group, because we obtained 
many of these specimens within several weeks 
of the veterans’ return from deployment. 
Closing this gap between potential exposure 
opportunity and sample collection and the 
fact that we are still observing normal urine U 
results gives some reassurance that large num-
bers of soldiers from previous conflicts likely 
did not incur urine U elevations that were 
missed because of the delay in sampling.
Even if participants in the Gulf War 
conflicts had transient exposure to DU, it 
is highly unlikely that this would result in 
significant, subsequent health effects for sev-
eral reasons. The clearance of U from the 
body is relatively rapid (nearly two-thirds of 
an acute dose is cleared through the kidney 
in 24 hr; Agency for Toxic Substances and 
Disease Registry 1999). Acute effects of U on 
the kidney (the primary target organ for solu-
ble U compounds) do not persist after short 
exposures, and only under chronic exposure 
conditions does accumulation of U in the 
kidney cause long-term effects (Royal Society 
of London 2002). In addition, the absence of 
expected effects is supported by findings from 
the DU Surveillance Program for friendly fire 
victims. In 15 years of follow-up, no clinically 
significant U-related health effects have been 
observed in the cohort, including those with 
retained DU fragments (McDiarmid et al. 
2000, 2001b, 2004b, 2006, 2007, 2009), 
except for subtle changes in renal proximal 
tubule markers in veterans with retained frag-
ments (McDiarmid et al. 2009).
To summarize, the U biomonitoring 
results obtained over three reporting peri-
ods—the present study and two previous 
reports (McDiarmid et al. 2001a; 2004a)—
have shown that > 95% of the 2,246 total 
urine specimens collected since 1998 had 
urine U concentrations similar to those found 
in the general U.S. population (CDC 2005), 
and all but one sample, which has a Unat iso-
topic signature, had U concentrations < the 
occupational decision level (0.8 µg/L) used 
by the Fernald Environmental Management 
Project for U-exposed workers (Fernauld 
Environmental Management Project 1997). 
In addition, review of exposure histories con-
firms previous findings that the presence of a 
retained DU fragment and history of friendly 
fire exposure are the best predictors of an ele-
vated urine U concentration.
This indicates that for most veterans who 
are concerned about exposure to DU as a result 
of their deployment, urine U concentrations 
outside the normal range are a rare occurrence 
and DU isotopic signatures are even more 
uncommon. No persistent urine U elevations 
have been detected in potentially exposed 
veterans without a history of DU-embedded 
fragments. This further suggests that future 
DU-related health harm is unlikely.
RefeRences
Agency for Toxic Substances and Disease Registry. 1999. 
Toxicological Profile for Uranium (Update). Washington, 
DC:U.S. Department of Health and Human Services, Public 
Health Service, Agency for Toxic Substances and Disease 
Registry.
Army Environmental Policy Institute. 1995. Health and 
Environmental Consequences of Depleted Uranium Use 
in the US Army. Atlanta, GA:Army Environmental Policy 
Institute.
Centers for Disease Control and Prevention. 2005. Third 
National Report on Human Exposure to Environmental 
Chemicals. Atlanta, GA:Centers for Disease Control and 
Prevention.
Dang HS, Pullat VR, Pillai KC. 1992. Determining the normal 
concentration of uranium in urine and application of the 
data to its biokinetics. Health Phys 62:562–566.
Ejnik EJ, Todorov T, Mullick FG, Squibb KS, McDiarmid MA, 
Centeno JA. 2005. Uranium analysis in urine by inductively 
coupled plasma dynamic reaction cell mass spectrometry. 
Anal Bioanal Chem 382:73–79.
Fernauld Environmental Management Project. 1997. Technical 
Basis for Internal Dosimetry at the Fernauld Environmental 
Management Project. FEMP Pub. SD 2008. Fernauld, 
OH:Fernauld Environmental Management Project.
Hahn FF, Guilmette RA, Hoover MD. 2002. Implanted depleted 
uranium fragments cause soft tissue sarcomas in the 
muscles of rats. Environ Health Perspect 110:51–59.
Kurttio P, Auvinen A, Salonen L, Saha H, Pekkanen J, 
Makelainen I, et al. 2002. Renal effects of uranium in drink-
ing water. Environ Health Perspect 110:337–342.
McDiarmid MA, Engelhardt SM, Oliver M, Gucer P, Wilson PD, 
Kane R, et al. 2007. Health surveillance of Gulf War I vet-
erans exposed to depleted uranium: updating the cohort. 
Health Phys 93:60–73.
McDiarmid MA, Engelhardt SM, Dorsey CS, Oliver M, Gucer 
P, Wilson PD, et al. 2009. Surveillance results of depleted 
uranium-exposed Gulf War veterans: sixteen years of 
follow-up. J Toxicol Environ Health Part A 72:14–29.
McDiarmid MA, Engelhardt SM, Oliver M, Gucer P, Wilson PD, 
Kane R, et al. 2004b. Health effects of depleted uranium on 
exposed Gulf War veterans: a 10-year follow-up. J Toxicol 
Environ Health Part A 67:277–296.
McDiarmid MA, Engelhardt SM, Oliver M, Gucer P, Wilson PD, 
Kane R, et al. 2006. Biological monitoring and surveillance 
results of Gulf War I veterans exposed to depleted ura-
nium. Int Arch Occup Environ Health 79:11–21.
McDiarmid MA, Engelhardt SM, Oliver M. 2001a. Urinary ura-
nium concentrations in an enlarged Gulf War veteran 
cohort. Health Phys 80:270–273.
McDiarmid MA, Keogh JP, Hooper FJ, McPhaul K, Squibb KS, 
Kane R, et al. 2000. Health effects of depleted uranium on 
exposed Gulf War veterans. Environ Res 82:168–180.
McDiarmid MA, Squibb K, Engelhardt S, Oliver M, Gucer P, 
Wilson PD, et al. 2001b. Surveillance of depleted uranium 
exposed Gulf War veterans: health effects observed in 
an enlarged “friendly fire” cohort. J Occup Environ Med 
43:991–1000.
McDiarmid MA, Squibb K, Engelhardt SM. 2004a. Biologic 
monitoring for urinary uranium in Gulf War I veterans. 
Health Phys 87:51–56.
Medley DW, Kathren RL, Miller AG. 1994. Diurnal urinary vol-
ume and uranium output in uranium workers and unex-
posed controls. Health Phys 67:122–130.
Orloff KG, Mistry K, Charp P, Metcalf S, Marino R, Shelly T, 
et al. 2004. Human exposure to uranium in groundwater. 
Environ Res 94:319–326.
Parkhurst MA, Daxon EG, Lodde GM, Szrom F, Guilmette RA, 
Falo RE, et al. 2005. Depleted Uranium Aerosol Doses 
and Risks: Summary of U.S. Assessments. Columbus, 
OH:Battelle Press.
Pellmar TC, Fuciarelli AF, Ejnik JW, Hamilton M, Hogan J, Strocko 
S, et al. 1999. Distribution of uranium in rats implanted with 
depleted uranium pellets. Toxicol Sci49:29–39.
Royal Society of London. 2002. The Health Effects of Depleted 
Uranium Munitions. Policy Document 6/01. London:Royal 
Society.
Thun MJ, Baker DB, Steenland K, Smith AB, Halperin W, Berl T. 
1985. Renal toxicity in uranium mill workers. Scand J Work 
Enviro Health 11:83–90.
Zamora ML, Tracy BL, Zielinski JM, Meyerhof DP, Moss MA. 
1998. Chronic ingestion of uranium in drinking water: a 
study of kidney bioeffects in humans. Toxicol Sci 47:68–77.